---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-117439"
form_type: "8-K"
ticker: "APVO"
cik: "0001671584"
company_name: "Aptevo Therapeutics Inc."
filed_at: "2024-10-25T23:59:59+00:00"
generated_at: "2026-05-30T10:04:49.577642+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Aptevo shareholders approve reverse stock split (1:5–1:37) and dilutive stock issuance

## Summary
- Stock issuance and warrant proposal passed (593,301 For, 412,901 Against, 5,355 Abstain).
- Reverse stock split approved at ratio of 1-for-5 to 1-for-37; board sets timing and exact ratio.
- Adjournment proposal also approved (2,017,270 For, 1,253,171 Against, 9,145 Abstain).
- Issuance covers >19.99% of outstanding common stock with price adjustment warrants per Sept 16 agreement.

## SEC filing metadata
- accession: 0000950170-24-117439
- form_type: 8-K
- ticker: APVO
- cik: 0001671584
- company_name: Aptevo Therapeutics Inc.
- filed_at: 2024-10-25T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1671584/000095017024117439/0000950170-24-117439-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1671584/000095017024117439/apvo-20241025.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-117439
- JSON: https://secwatch.observer/filing/0000950170-24-117439.json
- Plain text: https://secwatch.observer/filing/0000950170-24-117439.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.